These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16554455)

  • 41. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R; Zech K; Bethke TD
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.
    Bronsky EA; Aaronson DW; Berkowitz RB; Chervinsky P; Graft D; Kaiser HB; Moss B; Nathan RA; Pearlman DS; Ratner PH; Adelglass JM; Southern DL; van Bavel J; Hampel F; Stricker WE; Fourré JA; Cuss FM; Nolop KB
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):51-6. PubMed ID: 9236500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ciclesonide is more effective than budesonide in the treatment of persistent asthma.
    Ukena D; Biberger C; Steinijans V; von Behren V; Malek R; Weber HH; Beck E; Linnhoff A
    Pulm Pharmacol Ther; 2007; 20(5):562-70. PubMed ID: 16962345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budesonide in grass pollen rhinitis.
    Norman PS; Creticos PS; Tobey R; Proud DG; Kagey-Sobotka A; Meyers DA; Persson T
    Ann Allergy; 1992 Oct; 69(4):309-16. PubMed ID: 1416266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI; Levy AL; Hampel FC; Baidoo CA; Cook CK; Philpot EE; Rickard KA
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis.
    Pullerits T; Praks L; Skoogh BE; Ani R; Lötvall J
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1814-8. PubMed ID: 10351924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 2005 May; 115(5):940-5. PubMed ID: 15867849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen.
    Ratner PH; Andrews C; Martin B; Howland W; Desai SY; Huang H; Hinkle J; Bode F
    Allergy Asthma Proc; 2012; 33(1):27-35. PubMed ID: 22370531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
    Mukker JK; Singh RSP; Derendorf H
    J Pharm Sci; 2016 Sep; 105(9):2509-2514. PubMed ID: 27339407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
    Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
    Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ciclesonide (Omaris) for allergic rhinitis.
    Med Lett Drugs Ther; 2008 May; 50(1285):33-4. PubMed ID: 18458668
    [No Abstract]   [Full Text] [Related]  

  • 55. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
    Feng S; Fan Y; Liang Z; Ma R; Cao W
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allergic rhinitis practice parameter update: correction to information regarding OMNARIS (ciclesonide) nasal spray.
    Karafilidis JG; Andrews WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1236. PubMed ID: 19084114
    [No Abstract]   [Full Text] [Related]  

  • 59. The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis.
    Yang Q; Wang F; Li B; Wu W; Xie D; He L; Xiang N; Dong Y
    Braz J Otorhinolaryngol; 2019; 85(3):371-378. PubMed ID: 30522830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide.
    Rohatagi S; Luo Y; Shen L; Guo Z; Schemm C; Huang Y; Chen K; David M; Nave R; King SP
    Am J Ther; 2005; 12(3):201-9. PubMed ID: 15891262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.